Skip to main content
Clinical Trials/CTRI/2025/09/094835
CTRI/2025/09/094835
Completed
Not Applicable

Dry Needling Versus Percutaneous Electrical Nerve Stimulation On Pain, Range Of Motion And Quality Of Life In Myogenous Masticatory Pain –A Randomized Controlled Trial

KLE Academy of Higher Education and Research1 site in 1 country36 target enrollmentStarted: October 25, 2025Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
KLE Academy of Higher Education and Research
Enrollment
36
Locations
1
Primary Endpoint
1. Pain severity - Numerical pain rating scale – NPRS

Overview

Brief Summary

This study is a randomized controlled trial evaluating the effectiveness of dry needling, percutaneous electrical nerve stimulation, conventional therapy [ultrasound and Rocabado exercises] in adults aged 18 to 40 years with myogenous masticatory pain MMP. Thirty six participants will be randomly assigned to one of three groups DN plus conventional, PENS plus conventional, or conventional only, each receiving treatment on alternate days for two weeks. Assessments include pain using NPRS and pain pressure threshold, jaw function JFLS 20 and maximum mouth opening, and quality of life OHIP14, with results analyzed for statistical significance. The aim is to determine which intervention provides the greatest improvements in pain relief, jaw mobility, and quality of life, thus guiding future clinical management in MMP cases where comparative data is lacking.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 40.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Subjects willing to participate.
  • Age group between 18 to 40 years of both genders Participants with MMP with limited mouth opening and stiffness according to the Diagnostic Criteria for Temporomandibular Disorders Muscle tenderness of any of the muscles of mastication.

Exclusion Criteria

  • All the red flags of dry needling.
  • Polyarthritis, OA and arthralgia.
  • Any coexisting Infections around face and neck, TMJ arthritis, occlusive disorders, fibromyalgia or any neurologic disorder such as trigeminal neuralgia.
  • Any systemic sickness or simultaneous condition that could affect the orofacial area and interfere with the study protocol.
  • Injuries, use of anticoagulants or medications for circulation issues, metal allergies, and individuals with cognitive or communicative impairments that can impede the gathering of essential data.

Outcomes

Primary Outcomes

1. Pain severity - Numerical pain rating scale – NPRS

Time Frame: baseline and end of two weeks

2. Pain pressure threshold (PPT) – Pressure algometer

Time Frame: baseline and end of two weeks

3. The jaw functional limitations scales (JFLS-20)

Time Frame: baseline and end of two weeks

4. Maximum Mouth opening – Vernier calliper

Time Frame: baseline and end of two weeks

5. Quality of life - Oral health impact profile (OHIP-14)

Time Frame: baseline and end of two weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
KLE Academy of Higher Education and Research
Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Preshita Shah

KAHER Institute Of Physiotherapy

Study Sites (1)

Loading locations...

Similar Trials